Non-Current Liabilities
Operating Lease Liabilities (Total)
West Pharmaceutical Services Operating Lease Liabilities (Total) decreased by 4.1% to $113.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.7%, from $100.60M to $113.40M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities (Total) shows an upward trend with a 10.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026
How to read this metric
An increase indicates expansion of the leased asset base, while a decrease suggests a reduction in lease commitments or the expiration of lease terms.
Detailed definition
This represents the total present value of future lease payments for operating leases, recognized as a liability on the...
Peer comparison
Standardized under modern accounting rules, allowing for direct comparison of lease-based financing across companies in the same sector.
Metric ID:
operating_lease_liabilities_totalHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $65.30M | $61.50M | $72.30M | $78.70M | $80.50M | $90.50M | $109.00M | $106.10M | $103.50M | $99.50M | $102.20M | $100.40M | $104.90M | $102.20M | $99.70M | $100.60M | $100.70M | $94.90M | $118.30M | $113.40M |
| QoQ Change | — | -5.8% | +17.6% | +8.9% | +2.3% | +12.4% | +20.4% | -2.7% | -2.5% | -3.9% | +2.7% | -1.8% | +4.5% | -2.6% | -2.4% | +0.9% | +0.1% | -5.8% | +24.7% | -4.1% |
| YoY Change | — | — | — | — | +23.3% | +47.2% | +50.8% | +34.8% | +28.6% | +9.9% | -6.2% | -5.4% | +1.4% | +2.7% | -2.4% | +0.2% | -4.0% | -7.1% | +18.7% | +12.7% |
Range$61.50M – $118.30M
CAGR+12.3%
Avg YoY Growth+12.8%
Median YoY Growth+6.3%
Operating Lease Liabilities (Total) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating lease liabilities (total)?
- West Pharmaceutical Services (WST) reported operating lease liabilities (total) of $113.40M in Q1 2026.
- How has West Pharmaceutical Services's operating lease liabilities (total) changed year-over-year?
- West Pharmaceutical Services's operating lease liabilities (total) increased by 12.7% year-over-year, from $100.60M to $113.40M.
- What is the long-term trend for West Pharmaceutical Services's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease liabilities (total) has grown at a 10.9% compound annual growth rate (CAGR), from $70.50M to $118.30M.
- What does operating lease liabilities (total) mean?
- The total value of future payments the company is obligated to make for leased assets.